1. Hengartner MP, Schulthess L, Sorensen A, Framer A. Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Ther Adv Psychopharmacol. 2020;10:2045125320980573. Published 2020 Dec 24. doi:10.1177/2045125320980573 [cited 2022 July 28]
2. Horowitz, MA, Taylor D, “Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet 2019 [Mar 4] [cited 2022 July 28]
3. FDA drug label Zoloft [sertraline hydrochloride} 1991 [cited 2022 July 28]
4. Read J, Williams J. “Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects.” Curr Drug Saf. 2018;13(3):176-186. doi: 10.2174/1574886313666180605095130. PMID: 29866014. [cited 2022 July 28]
5. Read J, Cartwright C, Gibson K. “Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants.” Psychiatry Res. 2014 Apr 30;216(1):67-73. doi: 10.1016/j.psychres.2014.01.042. Epub 2014 Feb 3. PMID: 24534123. [cited 2022 July 28]
6. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci. 2008;33(4):331-343. [cited 2022 July 28]
7. Penckofer S, Kouba J, Byrn M, Estwing Ferrans C. Vitamin D and depression: where is all the sunshine?. Issues Ment Health Nurs. 2010;31(6):385-393. doi:10.3109/01612840903437657. [cited 2022 July 28]
8. Understanding nutrition, depression and mental illnesses Indian J Psychiatry. 2008 Apr-Jun; 50(2): 77–82. T. S. Sathyanarayana Rao, M. R. Asha, B. N. Ramesh, and K. S. Jagannatha Rao [cited 2022 July 28]
9. Is There a Connection Between Food Allergies and Mental Health? Integrative Psychiatry 2012 Sep 6 [cited 2022 July 28]
10. Kristin Filler, Debra Lyon, James Bennett, Nancy McCain, Ronald Elswick, Nada Lukkahatai, and Leorey N. Saligan Association of mitochondrial dysfunction and fatigue: A review of the literature BBA Clin. 2014 Jun; 1: 12–23.Published online 2014 Apr 13. doi: 10.1016/j.bbacli.2014.04.001. [cited 2022 July 28]
11. Environmental Exposures and Depression: Biological Mechanisms and Epidemiological Evidence Annual Review of Public Health Vol. 40:239-259 (Volume publication date April 2019) First published as a Review in Advance on January 11, 2019 [cited 2022 July 28]
12. Hengartner MP, Davies J, Read J. Antidepressant withdrawal – the tide is finally turning. Epidemiol Psychiatr Sci. 2019;29:e52. Published 2019 Aug 22. doi:10.1017/S2045796019000465 [cited 2022 July 28]
13. Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry. 2009 Aug;70(8):1069-77. doi: 10.4088/JCP.08m04943. PMID: 19758520. [cited 2022 July 28]
14. Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017;189(21):E747. doi:10.1503/cmaj.160991. [cited 2022 July 28]
15. Mad in America Ambushed by Antidepressant Withdrawal: The Escape Story By Derek Blumke September 27, 2019. [cited 2022 July 28]
16. Mourad I, Lejoyeux M, Adès J. Evaluation prospective du sevrage des antidépresseurs [Prospective evaluation of antidepressant discontinuation]. Encephale. 1998 May-Jun;24(3):215-22. French. PMID: 9696914. .[cited 2022 July 28]
17. Henssler J, Heinz A, Brandt L, Bschor T. Antidepressant Withdrawal and Rebound Phenomena. Dtsch Arztebl Int. 2019;116(20):355-361. doi:10.3238/arztebl.2019.0355. [cited 2022 July 28]
18. Bio Space Pfizer Zoloft Co-Inventor Ken Koe Dies at 90 Years of Age Published: Oct 14, 2015 By Mark Terry, BioSpace.com Breaking News Staff. [cited 2022 July 28]
19. Llamas M, reviewed by Dr. A Ali, Zoloft Drug Watch [May 16, 2022] [cited 2022 July 28]
20. Psychotropical Research SSRIs – Sertraline by Dr Ken Gillman Published Nov 14, 2014. [cited 2022 July 28]
21. Nakamura T, Sugiyama N, Sasayama D, Hagiwara T, Washizuka S. Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline. Case Rep Psychiatry. 2017;2017:1319505. doi:10.1155/2017/1319505. [cited 2022 July 28]
22. Dunlop BW, Nemeroff CB. The Role of Dopamine in the Pathophysiology of Depression. Arch Gen Psychiatry. 2007;64(3):327–337. doi:10.1001/archpsyc.64.3.327. [cited 2022 July 28]
23. Birth Injury Guide Zoloft Lawsuit Filed by California Mom Page Updated on September 17, 2018. [cited 2022 July 28]
24. ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation by CARRIE ARMSTRONG Am Fam Physician. 2008 Sep 15;78(6):772-778.[cited 2022 July 28]
25. FDA Research, Policy and Workshops on Women in Clinical Trials [06/06/2019] [cited 2022 July 28]
26. Shields KE, Lyerly AD. Exclusion of pregnant women from industry-sponsored clinical trials. Obstet Gynecol. 2013 Nov;122(5):1077-1081. doi: 10.1097/AOG.0b013e3182a9ca67. PMID: 24104789. [cited 2022 July 28]
27. Mother to Baby Sertraline (Zoloft®) December 2, 2019. [cited 2022 July 28]
28. Bérard A, Zhao JP, Sheehy O. Sertraline use during pregnancy and the risk of major malformations. Am J Obstet Gynecol. 2015 Jun;212(6):795.e1-795.e12. doi: 10.1016/j.ajog.2015.01.034. Epub 2015 Jan 28. PMID: 25637841. [cited 2022 July 28]
29. FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies 12-14-2011. [cited 2022 July 28]
30. Carey Danis & Lowe Attorneys at Law Zoloft Lawsuits – CLASS ACTION LAWYERS FOR SIDE EFFECTS INCREASED RISK OF CONGENITAL HEART DEFECTS IN WOMEN AND NEWBORNS. [cited 2022 July 28]
31. Takoua Boukhris et al., Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children JAMA Pediatr 2016;170(2):117-124. doi:10.1001/jamapediatrics.2015.3356 [cited 2022 July 28]
32. Yazdy MM, Mitchell AA, Louik C, Werler MM. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology. 2014;25(6):859-865. doi:10.1097/EDE.0000000000000157. [cited 2022 July 28]
33. MISSD Another Firsthand Experience and Description of the Terrors of Akathisia December 2, 2017. [cited 2022 July 28]
34. American Journal of Gynecology Sertraline use during pregnancy and the risk of major malformations Anick Bérard, MSc, PhD, Jin-Ping Zhao, MD, PhD, Odile Sheehy, MSc Published: January 28, 2015.[cited 2022 July 28]
35. Sansone RA, Sansone LA. SSRI-Induced Indifference. Psychiatry (Edgmont). 2010;7(10):14-18. [cited 2022 July 28]
36. Paul W. Andrews, Susan G. Kornstein, Lisa J. Halberstadt, Charles O. Gardner and Michael C. Neale, Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression Front. Psychol., 07 July 2011. [cited 2022 July 28]
37. Andrews PW, et al Blue Again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front Psychol 7 July 2011 [cited 2022 July 28]
38. Sharma T, Guski LS, Freund N, Gøtzsche PC. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ. 2016 Jan 27;352:i65. doi: 10.1136/bmj.i65. PMID: 26819231; PMCID: PMC4729837. [cited 2022 July 28]
39. PLOS Medicine Antidepressants and Violence: Problems at the Interface of Medicine and Law David Healy, Andrew Herxheimer, David B Menkes Published: September 12, 2006. [cited 2022 July 28]
40. Singh HK, Saadabadi A. Sertraline. [Updated 2022 Feb 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547689/ [cited 2022 July 28]
41. Petrova NN, Markin AV. Sindrom apatii u depressivnykh patsientov, poluchavshikh lechenie selektivnymi ingibitorami obratnogo zakhvata serotonina [Apathy syndrome in depressed patients previously treated with selective serotonin reuptake inhibitors]. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(1):111-117. Russian. doi: 10.17116/jnevro2020120011111. PMID: 32105278. [cited 2022 July 28]
42. Luft MJ, Lamy M, DelBello MP, McNamara RK, Strawn JR. Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management. Curr Probl Pediatr Adolesc Health Care. 2018;48(2):50-62. doi:10.1016/j.cppeds.2017.12.001. [cited 2022 July 28]
43. NIH US National Library of Medicine Pharmacogenetics of Antidepressant-Induced Disinhibition (PGx-AID) First Posted: May 16, 2019.[cited 2022 July 28]
44. James Davies, John Read, A systematic review into the incidence, severity, and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors Volume 97, 2019, Pages 111-121, ISSN 0306-4603. [cited 2022 July 28]
45. Read J. How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients. Addict Behav. 2020 Mar;102:106157. doi: 10.1016/j.addbeh.2019.106157. Epub 2019 Nov 30. PMID: 31841871. [cited 2022 July 28]
46. Tan KR, Rudolph U, Lüscher C. Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci. 2011;34(4):188-197. doi:10.1016/j.tins.2011.01.004. [cited 2022 July 28]
47. Pétursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994 Nov;89(11):1455-9. doi: 10.1111/j.1360-0443.1994.tb03743.x. PMID: 7841856. [cited 2022 July 28]
48. Daily MED LABEL: SERTRALINE HYDROCHLORIDE tablet, film-coated DRUG LABEL INFORMATION Updated August 4, 2010. [cited 2022 July 28]
49. Marken PA, Munro JS. Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features. Prim Care Companion J Clin Psychiatry. 2000;2(6):205-210. doi:10.4088/pcc.v02n0602 [cited 2022 July 28]
50. Brendel DH, Bodkin JA, Yang JM. Massive sertraline overdose. Ann Emerg Med. 2000 Nov;36(5):524-6. doi: 10.1067/mem.2000.111575. PMID: 11054208. [cited 2022 July 28]
51. Nelson LS, Erdman AR, Booze LL, Cobaugh DJ, Chyka PA, Woolf AD, Scharman EJ, Wax PM, Manoguerra AS, Christianson G, Caravati EM, Troutman WG. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007 May;45(4):315-32. doi: 10.1080/15563650701285289. PMID: 17486478 [cited 2022 July 28]
52. Prathikanti S, Rivera R, Cochran A, Tungol JG, Fayazmanesh N, Weinmann E. Treating major depression with yoga: A prospective, randomized, controlled pilot trial. PLoS One. 2017;12(3):e0173869. Published 2017 Mar 16. doi:10.1371/journal.pone.0173869 [cited 2022 July 28]
53. Rivera E, Sison G, “Does Taking Zoloft Cause Weight Gain?” USA RX [2021 Mar 12, updated 2021 April 12] [cited 2022 July 28]
54. Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet. 1997;32 Suppl 1:22-30. doi: 10.2165/00003088-199700321-00004. PMID: 9068932. [cited 2022 July 28]
55. Wilson E, Lader M. A review of the management of antidepressant discontinuation symptoms. Ther Adv Psychopharmacol. 2015;5(6):357-368. doi:10.1177/2045125315612334 [cited 2022 July 28]
56. FDA label Xanax (alprazolam) tablets [cited 2022 July 28]
57. Ait-Daoud N, Hamby AS, Sharma S, Blevins D. A Review of Alprazolam Use, Misuse, and Withdrawal. J Addict Med. 2018;12(1):4-10. doi:10.1097/ADM.0000000000000350 [cited 2022 July 28]
58. Papp A, Onton JA. Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation. Prim Care Companion CNS Disord. 2018 Dec 20;20(6):18m02311. doi: 10.4088/PCC.18m02311. PMID: 30605268. [cited 2022 July 28]
59. Zawertailo LA, Busto U, Kaplan HL, Sellers EM. Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans. J Clin Psychopharmacol. 1995 Apr;15(2):117-24. doi: 10.1097/00004714-199504000-00007. Erratum in: J Clin Psychopharmacol 1995 Jun;15(3):239. PMID: 7782484. [cited 2022 July 28]